Cymarin
Chemical compound
- C01AC03 (WHO)
- (3S,5S,8R,10S,13R,14S,17R)-5,14-dihydroxy-3-((2R,4S,5S,6R)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
- 508-77-0 Y
- 441853
- 390429 N
- UK3LS8435E
- ChEMBL1651908 Y
- DTXSID20871714
- Interactive image
- O=C\1OC/C(=C/1)[C@H]2CC[C@@]6(O)[C@]2(C)CC[C@H]4[C@H]6CC[C@]5(O)C[C@@H](O[C@@H]3O[C@@H]([C@@H](O)[C@@H](OC)C3)C)CC[C@]45C=O
InChI
- InChI=1S/C30H44O9/c1-17-26(33)23(36-3)13-25(38-17)39-19-4-9-28(16-31)21-5-8-27(2)20(18-12-24(32)37-15-18)7-11-30(27,35)22(21)6-10-29(28,34)14-19/h12,16-17,19-23,25-26,33-35H,4-11,13-15H2,1-3H3/t17-,19+,20-,21+,22-,23+,25+,26-,27-,28+,29+,30+/m1/s1 Y
- Key:XQCGNURMLWFQJR-ZNDDOCHDSA-N Y
Cymarin (or cymarine) is a cardiac glycoside. Plants of the genus Apocynum, including Apocynum cannabinum and Apocynum venetum, contain cymarin.[1] Cymarin is a cardiac glycoside and an anti-arrhythmia and cardiotonic agent.[2]
References
External links
- Media related to Cymarin at Wikimedia Commons
- v
- t
- e
Bufo | |
---|---|
Scilla | |
Kalanchoe |
Digitalis | |
---|---|
Strophanthus |
|
Thevetia |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e